期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

低分子肝素在血液透析中的应用 被引量：1

Application of low molecular weight heparin in hemodialysis
原文传递
导出
摘要 低分子肝素(LMWH)与普通肝素相比具有抗凝作用强、生物利用度高、血浆半衰期长等优点,且极少引起血脂代谢紊乱及骨代谢异常,在临床血液透析治疗中应用较广。本文综述LMWH在血液透析中的应用现状。 Compared with unfractionated heparin, Low molecular weight heparin （LMWH） has significant anti-coagulation activity, high bioavailability and longer half-life. In addition, the effect on serum lipids and bone metabolism is favourable. LMWH is found to have an established role in hemodialysis. This review describes the application of LMWH in hemodialysis.
作者 霍苗苗 余毅
机构地区 南京军区福州总医院血液净化科
出处 《世界临床药物》 CAS 2014年第2期88-91,共4页 World Clinical Drug
关键词 低分子肝素(LMWH) 血液透析 应用 low molecular weight heparin （LMWH） hemodialysis application
分类号 R459.5 [医药卫生—治疗学] R973.2 [医药卫生—药品]
  • 相关文献

参考文献16

  • 1Jeffrey I,Weitz MD. Low- molecular-weight heparins [J]. NEngl J Med, 1997, 337 (21): 688-697.
  • 2Hirsh J, Bauer KA, Donati MB, et al. American college ofchest physicians (2008) parenteral anticoagulants: Americancollege of chest physicians evidence-based clinical practiceguidelines (8th edition) [J]. Chest, 2008,133(6 Suppl):141S-159S.
  • 3Antignani PL, Goffredo C, Pepe LL, et al Low-molecular-weight-heparins: a review of literature [J]. Vascular DisPrevention, 2008,5 (3): 190-199.
  • 4Fareed J, Leong W,Hoppensteadt DA, et al. Developmentof generic low molecular weight heparins: a perspective [J].Hematol Oncol Clin North Am, 2005,19 (1): 53-68.
  • 5Schmid P, Fischer AG, Wuillemin WA. Low-molecular-weight heparin in patients with renal insufficiency [J]. SwissMed Wkly, 2009, 139 (31-32): 438-452.
  • 6Lord H, Jean N, Dumont M, et al. Comparison betweentinzaparin and standard heparin for chronic haemodialy-sis ina Canadian centre [J]. Am J Nephrol, 2002, 22 (1): 58-66.
  • 7Davenport A, Lai KN, Hertel J, et al. Anticoagulation.In:Daugirdas JT, Blake PG, Ing TS (eds). Handbook ofDialysis, 4th edn [M]. Amsterdam: Wolters Kluwer Health,2007: 204-218.
  • 8肖青,孙雪峰,张冬,马志芳,吴明歌,王慧,陈香美.血液透析患者肝素和低分子量肝素的合理剂量[J].中华医学杂志,2010,90(3):187-191. 被引量：5
  • 9Leu JG, Chiang SS, Lin SM, et al. Low molecular weightheparin in hemodialysis patients with a bleeding tendency [J].Nephron, 2000, 86(4): 499-501.
  • 10Davenport A. Review article: Low-molecular-weight heparinas an alternative anticoagulant to unfractionated heparin forroutine outpatient haemodialysis treatments [ J]. Nephrology,2009, 14(5):455-461.

二级参考文献7

  • 1Shibata T, Sasaki Y, Hattori K, et al. Sonoclot analysis in cardiac surgery in dialysis-dependent patients. Ann Thorac Surg, 2004, 77:220-225.
  • 2Furuhashi M, Ura N, Hasegawa K, et al. Sonoclot coagulation analysis; new bedside monitoring for determination of the appropriate heparin dose during haemodialysis. Nephrol Dial Transplant, 2002, 17 : 1457-1462.
  • 3Bindi ML, Biancofiore GD, Consani G,et al. Blood coagulation monitoring during liver transplantation: Sonoclot analysis and laboratory tests. Minerva Anestesiol, 2001, 67:359-369.
  • 4Sylvie Lavaud, Erie Canivet, Anne Wuillai, et al. Optimal antieoagulation strategy in haemodialysis with heparin-coated polyaerylonitrile membrane . Nephrol Dial Transplant, 2003, 18: 2097-2104.
  • 5Warkentin TE. Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia. Arch Pathol Lab Med, 2002, 126:1415-1423.
  • 6孙雪峰,肖青,王禹,郝丽荣,林洪丽,张智敏,李冀军,陈香美.七个血液净化中心842例血液透析患者抗凝方法的流行病学调查及分析[J].中华医学杂志,2009,89(9):577-581. 被引量：16
  • 7张莉,孙雪峰,张冬,马志芳,茅玉梅,魏日胞,陈香美.不同抗凝剂对血液透析过程凝血状态的影响[J].中华肾脏病杂志,2009,25(5):335-340. 被引量：17

共引文献4

同被引文献5

引证文献1

世界临床药物
2014年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部